SlideShare a Scribd company logo
Outlines
 1- Introduction
 2- Role of DTC
 3- Outcomes of DTP analysis
Introduction
- 1
- The P&T committee is a multidisciplinary, evidence-
based process employed by an organization to select and
use medications that offer the best therapeutic outcomes
while minimizing potential risks and costs for patients.
- The P&T committee provides an evaluative, educational,
and advisory service to the medical staff and
organizational administration in all matters pertaining to
the use of available medications.
Role of DTC
- 2
1- Medication-use evaluation (MUE)
2-Adverse drug event monitoring and reporting
3-Medication error prevention
4-Medication safety
5-Development of clinical care plans and
medication management initiatives (e.g., practice
protocols, restrictions, guidelines and clinical
pathways).
Role in NIUN
DTC in NIUN
We consider cost
effectiveness, safety and
compliance of the patient
while comparing
medications of the same
group or other
alternatives
We use a structured, evidence-
based process in the evaluation of
medications for formulary
consideration by providing
information that reflects a
thorough, accurate, and unbiased
review and analysis of the evidence
available in the scientific literature
Development and
implementation of
clinical practice
guidelines
antibiotic policy in
Urology
department

More Related Content

Similar to DTC - Copy.pptx

PTC committee pharmacy and therapeutic c
PTC committee pharmacy and therapeutic cPTC committee pharmacy and therapeutic c
PTC committee pharmacy and therapeutic c
DiptoKumerSarker
 
Signifcance of pharmacovigilance & risk management plan
Signifcance of pharmacovigilance & risk management planSignifcance of pharmacovigilance & risk management plan
Signifcance of pharmacovigilance & risk management plan
Ansuman Parida
 
Drug utilization evaluation
Drug utilization evaluationDrug utilization evaluation
Drug utilization evaluation
Veena Suresh
 
Pharmacovigilance of Natural Drugs.
Pharmacovigilance of Natural Drugs.Pharmacovigilance of Natural Drugs.
Pharmacovigilance of Natural Drugs.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Hospital and Clinical Pharmacy Chapter -2
Hospital and Clinical Pharmacy Chapter -2Hospital and Clinical Pharmacy Chapter -2
Hospital and Clinical Pharmacy Chapter -2
Nikita Gupta
 
passive_serviallance and responsibilities in pharmacovigilance pptx
passive_serviallance and responsibilities in pharmacovigilance pptxpassive_serviallance and responsibilities in pharmacovigilance pptx
passive_serviallance and responsibilities in pharmacovigilance pptx
Ayodhya Paradhe
 
Introduction to Pharmacotherapeutics.pptx
Introduction to Pharmacotherapeutics.pptxIntroduction to Pharmacotherapeutics.pptx
Introduction to Pharmacotherapeutics.pptx
SHIVANEE VYAS
 
Introduction to Pharmacotherapeutics.pptx
Introduction to Pharmacotherapeutics.pptxIntroduction to Pharmacotherapeutics.pptx
Introduction to Pharmacotherapeutics.pptx
Mokshada Bhirud
 
From Laboratory to Patient
From Laboratory to PatientFrom Laboratory to Patient
From Laboratory to Patient
EURORDIS Rare Diseases Europe
 
IND Data Requirements and US FDA Submission Process.pdf
IND Data Requirements and US FDA Submission Process.pdfIND Data Requirements and US FDA Submission Process.pdf
IND Data Requirements and US FDA Submission Process.pdf
ProRelixInfo
 
Clinical Trials_1_Fundamentals_Randomised Clinical Trials.pptx
Clinical Trials_1_Fundamentals_Randomised Clinical Trials.pptxClinical Trials_1_Fundamentals_Randomised Clinical Trials.pptx
Clinical Trials_1_Fundamentals_Randomised Clinical Trials.pptx
Ram Arya
 
Drug utilisation evaluation
Drug utilisation evaluation Drug utilisation evaluation
Drug utilisation evaluation
Irene Vadakkan
 
Clinical reaserch 112070804001
Clinical reaserch 112070804001Clinical reaserch 112070804001
Clinical reaserch 112070804001
Patel Parth
 
3.PHARMACYTHERAPEUTICCOMMITTEEPTC.pptx
3.PHARMACYTHERAPEUTICCOMMITTEEPTC.pptx3.PHARMACYTHERAPEUTICCOMMITTEEPTC.pptx
3.PHARMACYTHERAPEUTICCOMMITTEEPTC.pptx
Deepali69
 
3.PHARMACYTHERAPEUTICCOMMITTEEPTC.pptx
3.PHARMACYTHERAPEUTICCOMMITTEEPTC.pptx3.PHARMACYTHERAPEUTICCOMMITTEEPTC.pptx
3.PHARMACYTHERAPEUTICCOMMITTEEPTC.pptx
Deepali69
 
Unit 3 drug utilization research (6hrs) march 12 2021
Unit 3 drug utilization research (6hrs) march 12 2021Unit 3 drug utilization research (6hrs) march 12 2021
Unit 3 drug utilization research (6hrs) march 12 2021
University of Gondar
 
Clinical reaserch 112070804001
Clinical reaserch 112070804001Clinical reaserch 112070804001
Clinical reaserch 112070804001Patel Parth
 
Health products and technologies Dr. Julius Ogato, Ministry of Health. Head...
Health products and technologies   Dr. Julius Ogato, Ministry of Health. Head...Health products and technologies   Dr. Julius Ogato, Ministry of Health. Head...
Health products and technologies Dr. Julius Ogato, Ministry of Health. Head...
Emmanuel Mosoti Machani
 
Clinical Trials.pptx
Clinical Trials.pptxClinical Trials.pptx
Clinical Trials.pptx
rehanrustam1
 

Similar to DTC - Copy.pptx (20)

PTC committee pharmacy and therapeutic c
PTC committee pharmacy and therapeutic cPTC committee pharmacy and therapeutic c
PTC committee pharmacy and therapeutic c
 
Signifcance of pharmacovigilance & risk management plan
Signifcance of pharmacovigilance & risk management planSignifcance of pharmacovigilance & risk management plan
Signifcance of pharmacovigilance & risk management plan
 
EOP.IM.S31
EOP.IM.S31EOP.IM.S31
EOP.IM.S31
 
Drug utilization evaluation
Drug utilization evaluationDrug utilization evaluation
Drug utilization evaluation
 
Pharmacovigilance of Natural Drugs.
Pharmacovigilance of Natural Drugs.Pharmacovigilance of Natural Drugs.
Pharmacovigilance of Natural Drugs.
 
Hospital and Clinical Pharmacy Chapter -2
Hospital and Clinical Pharmacy Chapter -2Hospital and Clinical Pharmacy Chapter -2
Hospital and Clinical Pharmacy Chapter -2
 
passive_serviallance and responsibilities in pharmacovigilance pptx
passive_serviallance and responsibilities in pharmacovigilance pptxpassive_serviallance and responsibilities in pharmacovigilance pptx
passive_serviallance and responsibilities in pharmacovigilance pptx
 
Introduction to Pharmacotherapeutics.pptx
Introduction to Pharmacotherapeutics.pptxIntroduction to Pharmacotherapeutics.pptx
Introduction to Pharmacotherapeutics.pptx
 
Introduction to Pharmacotherapeutics.pptx
Introduction to Pharmacotherapeutics.pptxIntroduction to Pharmacotherapeutics.pptx
Introduction to Pharmacotherapeutics.pptx
 
From Laboratory to Patient
From Laboratory to PatientFrom Laboratory to Patient
From Laboratory to Patient
 
IND Data Requirements and US FDA Submission Process.pdf
IND Data Requirements and US FDA Submission Process.pdfIND Data Requirements and US FDA Submission Process.pdf
IND Data Requirements and US FDA Submission Process.pdf
 
Clinical Trials_1_Fundamentals_Randomised Clinical Trials.pptx
Clinical Trials_1_Fundamentals_Randomised Clinical Trials.pptxClinical Trials_1_Fundamentals_Randomised Clinical Trials.pptx
Clinical Trials_1_Fundamentals_Randomised Clinical Trials.pptx
 
Drug utilisation evaluation
Drug utilisation evaluation Drug utilisation evaluation
Drug utilisation evaluation
 
Clinical reaserch 112070804001
Clinical reaserch 112070804001Clinical reaserch 112070804001
Clinical reaserch 112070804001
 
3.PHARMACYTHERAPEUTICCOMMITTEEPTC.pptx
3.PHARMACYTHERAPEUTICCOMMITTEEPTC.pptx3.PHARMACYTHERAPEUTICCOMMITTEEPTC.pptx
3.PHARMACYTHERAPEUTICCOMMITTEEPTC.pptx
 
3.PHARMACYTHERAPEUTICCOMMITTEEPTC.pptx
3.PHARMACYTHERAPEUTICCOMMITTEEPTC.pptx3.PHARMACYTHERAPEUTICCOMMITTEEPTC.pptx
3.PHARMACYTHERAPEUTICCOMMITTEEPTC.pptx
 
Unit 3 drug utilization research (6hrs) march 12 2021
Unit 3 drug utilization research (6hrs) march 12 2021Unit 3 drug utilization research (6hrs) march 12 2021
Unit 3 drug utilization research (6hrs) march 12 2021
 
Clinical reaserch 112070804001
Clinical reaserch 112070804001Clinical reaserch 112070804001
Clinical reaserch 112070804001
 
Health products and technologies Dr. Julius Ogato, Ministry of Health. Head...
Health products and technologies   Dr. Julius Ogato, Ministry of Health. Head...Health products and technologies   Dr. Julius Ogato, Ministry of Health. Head...
Health products and technologies Dr. Julius Ogato, Ministry of Health. Head...
 
Clinical Trials.pptx
Clinical Trials.pptxClinical Trials.pptx
Clinical Trials.pptx
 

More from HebaLatif1

Kornetsky 1- Investigators' Responsibility PRINTABLE.pdf
Kornetsky 1- Investigators' Responsibility PRINTABLE.pdfKornetsky 1- Investigators' Responsibility PRINTABLE.pdf
Kornetsky 1- Investigators' Responsibility PRINTABLE.pdf
HebaLatif1
 
Healthcare Center Website by Slidesgo.pptx
Healthcare Center Website by Slidesgo.pptxHealthcare Center Website by Slidesgo.pptx
Healthcare Center Website by Slidesgo.pptx
HebaLatif1
 
Kornetsky 3- Children and Adolescents PRINTABLE.pptx
Kornetsky 3- Children and Adolescents PRINTABLE.pptxKornetsky 3- Children and Adolescents PRINTABLE.pptx
Kornetsky 3- Children and Adolescents PRINTABLE.pptx
HebaLatif1
 
very nice.pptx
very nice.pptxvery nice.pptx
very nice.pptx
HebaLatif1
 
covid scientific day.pptx
covid scientific day.pptxcovid scientific day.pptx
covid scientific day.pptx
HebaLatif1
 
Lyme Disease by Slidesgo.pptx
Lyme Disease by Slidesgo.pptxLyme Disease by Slidesgo.pptx
Lyme Disease by Slidesgo.pptx
HebaLatif1
 
covid 19 medications.pptx
covid 19 medications.pptxcovid 19 medications.pptx
covid 19 medications.pptx
HebaLatif1
 

More from HebaLatif1 (7)

Kornetsky 1- Investigators' Responsibility PRINTABLE.pdf
Kornetsky 1- Investigators' Responsibility PRINTABLE.pdfKornetsky 1- Investigators' Responsibility PRINTABLE.pdf
Kornetsky 1- Investigators' Responsibility PRINTABLE.pdf
 
Healthcare Center Website by Slidesgo.pptx
Healthcare Center Website by Slidesgo.pptxHealthcare Center Website by Slidesgo.pptx
Healthcare Center Website by Slidesgo.pptx
 
Kornetsky 3- Children and Adolescents PRINTABLE.pptx
Kornetsky 3- Children and Adolescents PRINTABLE.pptxKornetsky 3- Children and Adolescents PRINTABLE.pptx
Kornetsky 3- Children and Adolescents PRINTABLE.pptx
 
very nice.pptx
very nice.pptxvery nice.pptx
very nice.pptx
 
covid scientific day.pptx
covid scientific day.pptxcovid scientific day.pptx
covid scientific day.pptx
 
Lyme Disease by Slidesgo.pptx
Lyme Disease by Slidesgo.pptxLyme Disease by Slidesgo.pptx
Lyme Disease by Slidesgo.pptx
 
covid 19 medications.pptx
covid 19 medications.pptxcovid 19 medications.pptx
covid 19 medications.pptx
 

Recently uploaded

Advantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO PerspectiveAdvantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO Perspective
Krisztián Száraz
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
The Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collectionThe Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collection
Israel Genealogy Research Association
 
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdfMASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
goswamiyash170123
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Normal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of LabourNormal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of Labour
Wasim Ak
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
JEE1_This_section_contains_FOUR_ questions
JEE1_This_section_contains_FOUR_ questionsJEE1_This_section_contains_FOUR_ questions
JEE1_This_section_contains_FOUR_ questions
ShivajiThube2
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
tarandeep35
 
South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)
Academy of Science of South Africa
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
deeptiverma2406
 
The Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptxThe Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptx
DhatriParmar
 

Recently uploaded (20)

Advantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO PerspectiveAdvantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO Perspective
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
The Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collectionThe Diamonds of 2023-2024 in the IGRA collection
The Diamonds of 2023-2024 in the IGRA collection
 
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdfMASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Normal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of LabourNormal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of Labour
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
JEE1_This_section_contains_FOUR_ questions
JEE1_This_section_contains_FOUR_ questionsJEE1_This_section_contains_FOUR_ questions
JEE1_This_section_contains_FOUR_ questions
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
 
South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
 
The Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptxThe Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptx
 

DTC - Copy.pptx

  • 1.
  • 2. Outlines  1- Introduction  2- Role of DTC  3- Outcomes of DTP analysis
  • 4. - The P&T committee is a multidisciplinary, evidence- based process employed by an organization to select and use medications that offer the best therapeutic outcomes while minimizing potential risks and costs for patients. - The P&T committee provides an evaluative, educational, and advisory service to the medical staff and organizational administration in all matters pertaining to the use of available medications.
  • 6. 1- Medication-use evaluation (MUE) 2-Adverse drug event monitoring and reporting 3-Medication error prevention 4-Medication safety 5-Development of clinical care plans and medication management initiatives (e.g., practice protocols, restrictions, guidelines and clinical pathways).
  • 8. DTC in NIUN We consider cost effectiveness, safety and compliance of the patient while comparing medications of the same group or other alternatives We use a structured, evidence- based process in the evaluation of medications for formulary consideration by providing information that reflects a thorough, accurate, and unbiased review and analysis of the evidence available in the scientific literature
  • 9. Development and implementation of clinical practice guidelines antibiotic policy in Urology department